ストックスクリーナーアプリを入手
4.50
2.97%
0.13
プレマーケット:
4.52
0.02
+0.44%
Corvus Pharmaceuticals Inc (CRVS) 最新ニュース
Can volume confirm reversal in Corvus Pharmaceuticals Inc.Stop Loss & Weekly Top Gainers Trade List - Newser
Is it time to cut losses on Corvus Pharmaceuticals Inc.July 2025 Short Interest & Capital Efficiency Focused Strategies - Newser
Can volume confirm reversal in Corvus Pharmaceuticals Inc. [Rate Cut]Long-Term Growth Plans - Newser
Sentiment analysis tools applied to Corvus Pharmaceuticals Inc.Long-Term Safety Investment Analysis Report - Newser
Corvus Pharmaceuticals and the 2025 Catalysts for Soquelitinib: A Dual-Target Biotech Play - AInvest
Corvus Pharmaceuticals: Positive Phase 1 Soquelitiinb Trial Data Brings 2025 Catalysts - Seeking Alpha
Does Corvus Pharmaceuticals Inc. qualify in momentum factor screeningFree High Accuracy Alerts for ROI Traders - Newser
Corvus Pharmaceuticals’ Earnings Call Highlights Progress - TipRanks
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Q2 2025 Earnings Call Transcript - Insider Monkey
Long term hold vs stop loss in Corvus Pharmaceuticals Inc.Watchlist Summary for Active Day Traders - Newser
What makes Corvus Pharmaceuticals Inc. stock price move sharplyFree Pattern Alert With ROI Driven Strategy - Newser
What to expect from Corvus Pharmaceuticals Inc. in the next 30 daysTechnical Analysis of Growth Stock Opportunities - Newser
How Corvus Pharmaceuticals Inc. stock performs during market volatilityStrong Balance Sheet Candidates - thegnnews.com
How to forecast Corvus Pharmaceuticals Inc. trends using time seriesMarket Correction Proof Stock Screening Analysis - Newser
Advanced analytics toolkit walkthrough for Corvus Pharmaceuticals Inc.Smart Risk Strategy with Entry Optimization - Newser
Published on: 2025-08-11 02:13:29 - Newser
Momentum divergence signals in Corvus Pharmaceuticals Inc. chartFree Triple Digit Return Stock Predictions - Newser
Is Corvus Pharmaceuticals Inc. stock ready for a breakoutTrend Analysis for Safer Market Entries - Newser
Price action breakdown for Corvus Pharmaceuticals Inc.Free Daily Growth Stock Pick Reports - Newser
Is Now a Good Time to Reenter Corvus Pharmaceuticals Inc.Scalable Portfolio Growth Suggestions Released - beatles.ru
Corvus (CRVS) Q2 Loss Beats Estimates - AOL.com
Real time pattern detection on Corvus Pharmaceuticals Inc. stockTechnical Insight Guide for Safer Trades - Newser
Corvus plans Phase II trial for soquelitinib in atopic dermatitis, targeting 200 patients with 12-week treatment window - MSN
Traders Watching For Reversal Pattern in Corvus Pharmaceuticals Inc.AI Trading Suggestions With Accuracy Focus Released - metal.it
Custom strategy builders for tracking Corvus Pharmaceuticals Inc.Free Pattern Detection for Entry Confirmation - Newser
What recovery options are there for Corvus Pharmaceuticals Inc.Real Chart Based Opportunity Identification - Newser
Transcript : Corvus Pharmaceuticals, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
Can technical indicators confirm Corvus Pharmaceuticals Inc.’s reversalFree Short Term Setup With Predictive Chart - Newser
Earnings call transcript: Corvus Pharmaceuticals’ Q2 2025 results show EPS beat By Investing.com - Investing.com South Africa
Earnings call transcript: Corvus Pharmaceuticals’ Q2 2025 results show EPS beat - Investing.com
Corvus Pharmaceuticals Inc (CRVS) Q2 2025 Earnings Call Highlights: Strategic Advances Amid ... By GuruFocus - Investing.com Canada
Published on: 2025-08-08 00:04:14 - Newser
Corvus Pharmaceuticals Reports Q2 2025 Progress and Financials - TipRanks
Corvus Pharmaceuticals Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Institutional scanner results for Corvus Pharmaceuticals Inc.Free Reliable Alerts for Daily Stock Movers - Newser
0.91%
3.06%
大文字化:
|
ボリューム (24 時間):